NCT05085977: Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)
- State
- Completed
- Phase
- Phase 1
- People
- 12 taking part
- Started
- 10 Mar 2022
- Primary completion
- 3 Sep 2024
- Arms
- TARA-002
- Results
- None posted
- 20 Oct 2021: Trial registered
- 10 Mar 2022: Trial started
- 30 Oct 2024: Trial completed